CB
AMPE

Christopher Bloomstran’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Christopher Bloomstran’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-33
Closed -$34K – 32
2014
Q4 		$34K Hold
33
– – 0.02% 30
2014
Q3 		$35K Hold
33
– – 0.02% 30
2014
Q2 		$84K Buy
+33
New +$67.3K 0.05% 29

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Christopher Bloomstran's AMPE Position: Q1 2015 in Review

Christopher Bloomstran sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2015, closing a stake of 33 shares — an estimated $34K sold.

Christopher Bloomstran first reported a position in AMPE in Q2 2014 and held it in 3 quarters. The position peaked at $84K in Q2 2014. 75 funds tracked by Wall St. Rank hold AMPE as of Q1 2015.

  • Christopher Bloomstran reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2015 after selling out during the quarter.
  • Christopher Bloomstran sold 33 Ampio Pharmaceuticals Inc. shares in Q1 2015, an estimated $34K.
  • Christopher Bloomstran first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 3 quarters.
  • Christopher Bloomstran's Ampio Pharmaceuticals Inc. position peaked at $84K in Q2 2014.
  • 75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2015.

Based on Semper Augustus Investments Group's 13F filing for Q1 2015, filed 14 May 2015.